echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The Safety of 6-Acetylpyridine-2-carboxylic acid ethyl ester

    The Safety of 6-Acetylpyridine-2-carboxylic acid ethyl ester

    • Last Update: 2023-05-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    6-Acetylpyridine-2-carboxylic acid ethyl ester, also known as APC-242, is a chemical compound that has been widely used in the industrial and pharmaceutical sectors.
    This compound is known for its ability to act as a potent and selective antagonist of the cannabinoid receptor type 2 (CB2).


    APC-242 is commonly used in research studies to investigate the potential therapeutic benefits of cannabinoids for a variety of medical conditions, including pain, inflammation, and anxiety.
    However, in recent years, there has been growing concern about the safety of APC-242, particularly in terms of its potential to cause adverse side effects.


    In this article, we will examine the current information available on the safety of APC-242, including its potential toxicity, as well as any precautions that should be taken when handling this compound.


    Toxicity of APC-242


    APC-242 is known to have a relatively high degree of potency as an antagonist of the CB2 receptor, and it is therefore important to be cautious when handling this compound.
    Despite this, there is limited information available on the toxicity of APC-242 in humans.


    However, animal studies have shown that APC-242 can produce adverse side effects at high doses.
    For example, a study published in the Journal of Pharmacology and Experimental Therapeutics found that APC-242 produced dose-dependent decreases in body weight and food consumption in rats, along with other signs of toxicity.


    Other studies have also shown that APC-242 can produce a range of adverse effects on the respiratory, cardiovascular, and central nervous systems of animals.
    For example, a study published in the European Journal of Pharmacology found that APC-242 produced dose-dependent decreases in lung function in rats, while another study published in the British Journal of Pharmacology found that APC-242 produced dose-dependent decreases in blood pressure in hypertensive rats.


    Precautions for handling APC-242


    Given the potential toxicity of APC-242, it is important to take precautions when handling this compound.
    If you are working with APC-242 in a laboratory or research setting, it is important to wear appropriate protective gear, including gloves, goggles, and a laboratory coat.
    Additionally, you should avoid touching your face or eyes while working with APC-242.


    It is also important to ensure that you are familiar with the proper handling and storage procedures for APC-242, as well as any relevant safety data sheets (SDS).
    If you are unsure about how to handle or store APC-242, it is recommended that you seek the advice of a qualified professional.


    Conclusion


    APC-242 is a compound with demonstrated potency as an antagonist of the CB2 receptor for cannabinoids, and it has been widely used in research studies to investigate the potential therapeutic benefits of cannabinoids for a range of medical conditions.
    While there is limited information available on the toxicity of APC-242 in humans, animal studies have shown that it can produce adverse side effects at high doses.


    It is important to take precautions when handling APC-242, including wearing appropriate protective gear and following proper handling and storage procedures.
    If you are unsure about how to handle or store APC-242, it is recommended that you seek the advice of a qualified professional.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.